Funding · Company
Triana Biomedicines, Inc.
Lexington, MABiotech & Pharma
Triana Biomedicines, Inc. of Lexington, MA has disclosed $163M across 2 Form D offerings filed with the SEC between Apr 19, 2022 and Dec 4, 2025.
$163M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$43M
Form D · Apr 19, 2022 ↗
Q2 2022
· 1 amendment, first filed Feb 11, 2022
· target $85M
Filing details
HeadquartersLexington, MAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2019SEC CIK0001815337Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →